Literature DB >> 16983711

p53--a natural cancer killer: structural insights and therapeutic concepts.

Lin Römer1, Christian Klein, Alexander Dehner, Horst Kessler, Johannes Buchner.   

Abstract

Every single day, the DNA of each cell in the human body is mutated thousands of times, even in absence of oncogenes or extreme radiation. Many of these mutations could lead to cancer and, finally, death. To fight this, multicellular organisms have evolved an efficient control system with the tumor-suppressor protein p53 as the central element. An intact p53 network ensures that DNA damage is detected early on. The importance of p53 for preventing cancer is highlighted by the fact that p53 is inactivated in more than 50 % of all human tumors. Thus, for good reason, p53 is one of the most intensively studied proteins. Despite the great effort that has been made to characterize this protein, the complex function and the structural properties of p53 are still only partially known. This review highlights basic concepts and recent progress in understanding the structure and regulation of p53, focusing on emerging new mechanistic and therapeutic concepts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16983711     DOI: 10.1002/anie.200600611

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  24 in total

1.  The architecture of functional modules in the Hsp90 co-chaperone Sti1/Hop.

Authors:  Andreas B Schmid; Stephan Lagleder; Melissa Ann Gräwert; Alina Röhl; Franz Hagn; Sebastian K Wandinger; Marc B Cox; Oliver Demmer; Klaus Richter; Michael Groll; Horst Kessler; Johannes Buchner
Journal:  EMBO J       Date:  2012-01-06       Impact factor: 11.598

2.  Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain.

Authors:  Mark Wells; Henning Tidow; Trevor J Rutherford; Phineus Markwick; Malene Ringkjobing Jensen; Efstratios Mylonas; Dmitri I Svergun; Martin Blackledge; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

3.  BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain.

Authors:  Franz Hagn; Christian Klein; Oliver Demmer; Natasha Marchenko; Angelina Vaseva; Ute M Moll; Horst Kessler
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

4.  Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction.

Authors:  Bing Shan; Da-Wei Li; Lei Brüschweiler-Li; Rafael Brüschweiler
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

Review 5.  The tumor suppressor p53: from structures to drug discovery.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02-10       Impact factor: 10.005

6.  Biophysical characterizations of human mitochondrial transcription factor A and its binding to tumor suppressor p53.

Authors:  Tuck Seng Wong; Sridharan Rajagopalan; Stefan M Freund; Trevor J Rutherford; Antonina Andreeva; Fiona M Townsley; Miriana Petrovich; Alan R Fersht
Journal:  Nucleic Acids Res       Date:  2009-09-15       Impact factor: 16.971

7.  Oligobenzamide proteomimetic inhibitors of the p53-hDM2 protein-protein interaction.

Authors:  Jeffrey P Plante; Thomas Burnley; Barbora Malkova; Michael E Webb; Stuart L Warriner; Thomas A Edwards; Andrew J Wilson
Journal:  Chem Commun (Camb)       Date:  2009-06-24       Impact factor: 6.222

8.  Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue.

Authors:  Brad D Wallentine; Ying Wang; Vira Tretyachenko-Ladokhina; Martha Tan; Donald F Senear; Hartmut Luecke
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-09-20

9.  Induction of apoptosis promoted by Bang52; a small molecule that downregulates Bcl-x(L).

Authors:  Matteo Rossi; Jeong-Kyu Bang; Sharlyn Mazur; Jaclyn A Iera; Darren C Phillips; Gerard P Zambetti; Daniel H Appella
Journal:  Bioorg Med Chem Lett       Date:  2009-03-21       Impact factor: 2.823

10.  Cyclic pifithrin-alpha sensitizes wild type p53 tumor cells to antimicrotubule agent-induced apoptosis.

Authors:  Valentina Zuco; Franco Zunino
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.